Los Angeles, CA -- (SBWIRE) -- 11/19/2018 -- This report studies the global market size of Antivenom in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antivenom in these regions.

This research report categorizes the global Antivenom market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.

The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.

Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/735987/global-antivenom-market

In 2017, the global Antivenom market size was 830 million US$ and is forecast to 1020 million US in 2025, growing at a CAGR of 2.6% from 2018. The objectives of this study are to define, segment, and project the size of the Antivenom market based on company, product type, application and key regions.

The various contributors involved in the value chain of Antivenom include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Antivenom include

CSL Behring

Merck & Co., Inc.

BTG Plc

Pfizer

Haffkine Bio-Pharmaceutical Corporation

Rare Disease Therapeutics

Flynn Pharma

Vins Bioproducts

Bharat Serums and Vaccines

Serum Biotech

Market Size Split by Type

Polyvalent antivenom

Monovalent antivenom

Market Size Split by Application

Retail Pharmacies

Hospitals

Others

Buy Full market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/c534c50959c21a4de602c8f38bf52bfe,0,1,Global%20Antivenom%20Market%20Insights%252C%20Forecast%20to%202025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.